PIONEERS: PHASE III TRIALS OF A NOVEL IMMUNOTHERAPY TO EVALUATE EFFICACY IN A RANGE OF TUMOR TYPES
Mark Identification

PIONEERS: PHASE III TRIALS OF A NOVEL IMMUNOTHERAPY TO EVALUATE EFFICACY IN A RANGE OF TUMOR TYPES

Serial Number

77741348

Filing Date

May 20, 2009

Trademark by

BRISTOL-MYERS SQUIBB COMPANY

Classification Information

Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use

Computer and Scientific